|1.||Eum, Ki-Hwan: 1 article (12/2015)|
|2.||Lee, Jeong-Won: 1 article (12/2015)|
|3.||Bae, Taejeong: 1 article (12/2015)|
|4.||Kim, Sungchul: 1 article (12/2015)|
|5.||Choi, Jin Woo: 1 article (12/2015)|
|6.||Weon, Kwon-Yeon: 1 article (12/2015)|
|7.||Clark, Ian: 1 article (08/2015)|
|8.||Rutka, James T: 1 article (08/2015)|
|9.||Faria, Claudia C: 1 article (08/2015)|
|10.||Kushida, Michelle: 1 article (08/2015)|
02/01/2005 - "Treatment of female polyps with the GSK3 inhibitors lithium and alsterpaullone prevents the differentiation of nurse cells and subsequent oocyte formation. "
02/01/2004 - "Upon iterated treatment with alsterpaullone, an inhibitor of GSK-3, the formation of additional, ectopic head structures and the budding of new polyps were dramatically accelerated and enhanced. "
|2.||Prostatic Neoplasms (Prostate Cancer)
02/01/2011 - "We evaluated the effects of aloisine A, alsterpaullone, aminopurvalanol, indirubin-3'-oxime, 6-Br-indirubin-3'-oxime, kenpaullone, olomoucine and roscovitine on cell proliferation, prostate-specific antigen (PSA) expression, androgen receptor (AR) activation, and GSK-3β and β-catenin expression in androgen-dependent LNCaP human prostate cancer cells. "
|3.||Ovarian Neoplasms (Ovarian Cancer)
08/28/2015 - "Specifically, we provide rationale for advancing alsterpaullone as a targeted therapy in Group 3 medulloblastoma. "
08/28/2015 - "Genomic profiling of Group 3 medulloblastoma cells treated with alsterpaullone confirmed inhibition of cell cycle-related genes, and down-regulation of MYC. "
08/28/2015 - "Alsterpaullone had the highest efficacy in Group 3 medulloblastoma cells. "
08/28/2015 - "Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma."
08/28/2015 - "The Connectivity Map (C-MAP) analysis identified piperlongumine as the top candidate drug for non-WNT medulloblastomas and the cyclin-dependent kinase (CDK) inhibitor alsterpaullone as the compound predicted to have specific antitumor activity against Group 3 medulloblastomas. "
|1.||Glycogen Synthase Kinase 3
|2.||Prostate-Specific Antigen (Semenogelase)
|5.||Androgen Receptors (Androgen Receptor)
|1.||Heterologous Transplantation (Xenotransplantation)